Theravance BiopharmaTBPH 
$9.850.61%24h
0.61%24h
Global rank11409
Market cap$490.51M
Change 7d3.47%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Theravance Biopharma (TBPH)
As of January 2025, Theravance Biopharma has a market cap of $490.51M. This makes Theravance Biopharma the world's 11409th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Theravance Biopharma from 2014 to 2024
-
Value:-
Market cap history of Theravance Biopharma from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $430.13M | -23.15% |
| 2023 | $559.73M | 0.18% |
| 2022 | $558.73M | 1.54% |
| 2021 | $550.27M | -37.82% |
| 2020 | $884.91M | -31.36% |
| 2019 | $1.29B | 1.17% |
| 2018 | $1.27B | -8.25% |
| 2017 | $1.39B | -12.52% |
| 2016 | $1.59B | 94.51% |
| 2015 | $816.19M | 9.85% |
| 2014 | $742.98M | - |
TBPH Market Cap Today is $490.51M 0.61% - 2 Jan 2025
View largest stocks by market cap 
